10 Dirt Cheap Stocks To Invest In Now

4. Bristol-Myers Squibb Company (NYSE:BMY)

Forward P/E Ratio: 7.49

Earnings Growth This Year: 489.15%

Number of Hedge Fund Holders: 88

Bristol-Myers Squibb Company (NYSE:BMY) is an international biopharmaceutical company that focuses on discovering and developing unique medicines across oncology, hematology, immunology, cardiovascular diseases, neuroscience, and fibrotic conditions. It has a robust portfolio of medicines including Opdivo, Yervoy, Orencia, Eliquis, and Revlimid.

Bristol-Myers Squibb Company (NYSE:BMY) had a robust fiscal 2024, driven by double-digit growth across its growth portfolio. The company reported quarterly revenue of $12.3 billion, reflecting 8% year-over-year growth. Its growth portfolio alone contributed $6.4 billion, reflecting a 21% increase year-over-year.

Apart from the financial achievements the company secured approval for Cobenfy and Opdivo Quvantic, which further strengthens its position in the United States market. It is working on medicines like Milvexian, Arlocell, and others, and expects multiple data rollouts in 2025. It is one of the dirt-cheap stocks to invest in now.